CAS: 859209-74-8 - GS-9219
Formel:C21H35N8O6P
InChl:InChI=1S/C21H35N8O6P/c1-5-34-19(30)13(3)27-36(32,28-14(4)20(31)35-6-2)12-33-10-9-29-11-23-16-17(24-15-7-8-15)25-21(22)26-18(16)29/h11,13-15H,5-10,12H2,1-4H3,(H2,27,28,32)(H3,22,24,25,26)/t13-,14-/m0/s1
InChI Key:InChIKey=ANSPEDQTHURSFQ-KBPBESRZSA-N
SMILES:O=C(OCC)C(NP(=O)(NC(C(=O)OCC)C)COCCN1C=NC=2C(=NC(=NC21)N)NC3CC3)C
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Rabacfosadine REF: TM-T16716CAS: 859209-74-8 | 98.75% - 99.43% | 153,00 €~1.573,00 € | Do 17 Okt 24 |
 | Rabacfosadine REF: 3D-JJB20974CAS: 859209-74-8 | Min. 95% | Nachfragen | Mo 25 Nov 24 |
Rabacfosadine
CAS:859209-74-8
Rabacfosadine (GS-9219) is a novel prodrug of PMEG, an acyclic nucleotide phosphonate, with antitumor activity …
Formel:
C21H35N8O6P
Reinheit:
98.75% - 99.43%
Farbe und Form:
Solid
Molekulargewicht:
526.53
Ref: TM-T16716
| 1mg | 153,00 € | ||
| 5mg | 364,00 € | ||
| 10mg | 542,00 € | ||
| 25mg | 869,00 € | ||
| 50mg | 1.179,00 € | ||
| 100mg | 1.573,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Donnerstag 17. Oktober 2024
Rabacfosadine
CAS:859209-74-8
Rabacfosadine is a novel antiviral drug that has been shown to be effective in the …
Formel:
C21H35N8O6P
Reinheit:
Min. 95%
Molekulargewicht:
526.5 g/mol
Ref: 3D-JJB20974
| 5mg | Nachfragen | ||
| 10mg | Nachfragen | ||
| 25mg | Nachfragen | ||
| 50mg | Nachfragen |
Voraussichtliche Lieferung in Vereinigte Staaten, am Montag 25. November 2024
